
CAS 1345982-69-5
:Formula:C28H38N2O7S
InChI:InChI=1S/C28H38N2O7S/c1-4-6-12-28(5-2)18-38(35,36)24-13-20(17-29-21(14-25(31)32)15-26(33)34)23(37-3)16-22(24)27(30-28)19-10-8-7-9-11-19/h7-11,13,16,21,27,29-30H,4-6,12,14-15,17-18H2,1-3H3,(H,31,32)(H,33,34)/t27-,28-/m1/s1
InChI key:CZGVOBIGEBDYTP-VSGBNLITSA-N
SMILES:CCCC[C@@]1(CS(=O)(=O)C2=C(C=C(C(=C2)CNC(CC(=O)O)CC(=O)O)OC)[C@H](N1)C3=CC=CC=C3)CC
Filter by
Purity percentage
0
100
|
0
|
50
|
90
|
95
|
100
Found 7 products.
- Lower prices
- Higher prices
- Lower purities
- Higher purities
- Faster estimated delivery
3-((((3R,5R)-3-Butyl-3-ethyl-7-methoxy-1,1-dioxido-5-phenyl-2,3,4,5-tetrahydrobenzo[f][1,4]thiazepin-8-yl)methyl)amino)pentanedioic acid
CAS:Formula:C28H38N2O7SPurity:%Molecular weight:546.6755Linerixibat
CAS:Linerixibat (GSK2330672) is a highly effective, nonabsorbable ASBT inhibitor. Linerixibat can lower glucose in an animal model of type 2 diabetes.Formula:C28H38N2O7SPurity:98.5% - 99.98%Color and Shape:SolidMolecular weight:546.676Linerixibat
CAS:3-((((3R,5R)-3-Butyl-3-ethyl-7-methoxy-1,1-dioxido-5-phenyl-2,3,4,5-tetrahydrobenzo[f][1,4]thiazepin-8-yl)methyl)amino)pentanedioic acidFormula:C28H38N2O7SPurity:98+%Molecular weight:546.68Linerixibat
CAS:Linerixibat is an investigational pharmaceutical compound classified as an ileal bile acid transporter (IBAT) inhibitor. It is derived from chemical synthesis and acts by selectively targeting the IBAT, also known as the apical sodium-dependent bile acid transporter (ASBT), located in the distal ileum of the small intestine. By inhibiting this transporter, Linerixibat reduces the reabsorption of bile acids from the intestinal lumen, which leads to increased fecal bile acid excretion and reduced systemic levels of bile acids.Formula:C28H38N2O7SPurity:Min. 95%Molecular weight:546.68 g/mol






